Steward Partners Investment Advisory’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9K | Sell |
2,726
-684
| -20% | -$17.5K | ﹤0.01% | 2297 |
|
|
2025
Q1 | $93.7K | Sell |
3,410
-4,847
| -59% | -$133K | ﹤0.01% | 2050 |
|
|
2024
Q4 | $223K | Sell |
8,257
-9
| -0.1% | -$243 | ﹤0.01% | 1547 |
|
|
2024
Q3 | $238K | Sell |
8,266
-9,496
| -53% | -$274K | ﹤0.01% | 1439 |
|
|
2024
Q2 | $484K | Sell |
17,762
-46,094
| -72% | -$1.26M | 0.01% | 1078 |
|
|
2024
Q1 | $1.79M | Buy |
63,856
+8,887
| +16% | +$249K | 0.02% | 612 |
|
|
2023
Q4 | $1.46M | Sell |
54,969
-1,703
| -3% | -$45.3K | 0.02% | 601 |
|
|
2023
Q3 | $1.45M | Buy |
56,672
+41,569
| +275% | +$1.06M | 0.02% | 550 |
|
|
2023
Q2 | $395K | Sell |
15,103
-67,540
| -82% | -$1.77M | 0.01% | 1018 |
|
|
2023
Q1 | $2.16M | Buy |
82,643
+14,744
| +22% | +$385K | 0.03% | 450 |
|
|
2022
Q4 | $1.86M | Buy |
67,899
+35,814
| +112% | +$982K | 0.03% | 470 |
|
|
2022
Q3 | $771K | Buy |
32,085
+31,670
| +7,631% | +$761K | 0.01% | 716 |
|
|
2022
Q2 | $11K | Hold |
415
| – | – | ﹤0.01% | 2483 |
|
|
2022
Q1 | $11K | Hold |
415
| – | – | ﹤0.01% | 2613 |
|
|
2021
Q4 | $11K | Hold |
415
| – | – | ﹤0.01% | 2557 |
|
|
2021
Q3 | $11K | Hold |
415
| – | – | ﹤0.01% | 2567 |
|
|
2021
Q2 | $11K | Hold |
415
| – | – | ﹤0.01% | 5855 |
|
|
2021
Q1 | $10.6K | Hold |
415
| – | – | ﹤0.01% | 2756 |
|
|
2020
Q4 | $11K | Hold |
415
| – | – | ﹤0.01% | 2271 |
|
|
2020
Q3 | $10K | Buy |
+415
| New | +$10K | ﹤0.01% | 2134 |
|